Zelluna ASA (ZLNA)

Oslo
Currency in NOK
14.00
-0.16(-1.13%)
Closed·
ZLNA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ZLNA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.7014.29
52 wk Range
12.0092.20
Key Statistics
Edit
Prev. Close
14.16
Open
13.8
Day's Range
13.7-14.29
52 wk Range
12-92.2
Volume
4.6K
Average Volume (3m)
15.38K
1-Year Change
-84.56%
Book Value / Share
6.28
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ZLNA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Zelluna ASA News & Analysis

Show more

Zelluna ASA Company Profile

As of March 3, 2025, Ultimovacs ASA was acquired by Zelluna Immunotherapy AS in a reverse merger transaction. Ultimovacs ASA, a biotech company, develops immunotherapies against cancers in Norway. Its lead product candidate is UV1, a peptide-based therapeutic cancer vaccine that induces a specific T cell response against the pan-tumor antigen telomerase. Ultimovacs ASA was incorporated in 2011 and is headquartered in Oslo, Norway.

Zelluna ASA Earnings Call Summary for Q1/2025

  • Zelluna ASA reported Q1 2025 operating loss of 29M NOK, pre-tax loss of 28M NOK; stock fell 6.11% post-announcement
  • Company maintains 135M NOK cash position, ensuring financial runway through Q2 2026; completed 51.7M NOK private placement
  • Advancing lead asset ZIm4.1 towards clinical submission in H2 2025; expects initial clinical data by 2026
  • Completed business combination and reverse share split in Q1 2025; anticipates reduced cash burn from operational synergies
  • CEO emphasizes 'game-changing' TCR NK cell therapy platform; CFO expects significant reduction in cash burn pre-clinical trials
Last Updated: 08/05/2025, 05:46 pm
Read Full Transcript

Compare ZLNA to Peers and Sector

Metrics to compare
ZLNA
Peers
Sector
Relationship
P/E Ratio
−2.9x−0.9x−0.5x
PEG Ratio
-−0.010.00
Price/Book
2.3x0.5x2.6x
Price / LTM Sales
5,514.9x4.9x3.1x
Upside (Analyst Target)
-417.2%47.0%
Fair Value Upside
Unlock38.0%−1.8%Unlock

Earnings

Latest Release
May 09, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ZLNA Income Statement

FAQ

What Is the Zelluna (ZLNA) Stock Price Today?

The Zelluna stock price today is 14.00

What Stock Exchange Does Zelluna Trade On?

Zelluna is listed and trades on the Oslo Stock Exchange stock exchange.

What Is the Stock Symbol for Zelluna?

The stock symbol for Zelluna is "ZLNA."

What Is the Zelluna Market Cap?

As of today, Zelluna market cap is 37.42M.

What Is Zelluna's Earnings Per Share (TTM)?

The Zelluna EPS (TTM) is -58.44.

When Is the Next Zelluna Earnings Date?

Zelluna will release its next earnings report on 19 Aug 2025.

From a Technical Analysis Perspective, Is ZLNA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Zelluna Stock Split?

Zelluna has split 1 times.

How Many Employees Does Zelluna Have?

Zelluna has 12 employees.

What is the current trading status of Zelluna (ZLNA)?

As of 12 June 2025, Zelluna (ZLNA) is trading at a price of 14.00, with a previous close of 14.16. The stock has fluctuated within a day range of 13.70 to 14.29, while its 52-week range spans from 12.00 to 92.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.